IRCT20170527034146N2
Completed
Phase 2
Evaluation of the occurrence, effect and side effects oFcyclophosfamid and rituximab in the tratment of children with NEPHROTIC SYNDROM resistance to STEROID that referred to Hazrate Massumeh hospital .
Ghoum University of Medical Sciences0 sites102 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Ghoum University of Medical Sciences
- Enrollment
- 102
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •?All patient whit nephrotic syndrome resistance to steroid whit age 1\-18 yr
Exclusion Criteria
- •All patient who do not have steroid\-resistant Nephrotic Syndrome for example patient with steroids depended syndrome.
- •All patient who did not accept treatment
- •All patient who died
- •All patient who did not follow up
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 4
Evaluation the possible side effects of rivaroxaban in patients with pulmonary valve replacement or Fontan surgery.IRCT20220516054868N2Esfahan University of Medical Sciences75
Completed
Phase 3
Effect of glucosamine in the treatment of psoriasisIRCT20200817048439N1Mashhad University of Medical Sciences30
Not yet recruiting
Phase 3
Evaluation of the effect of Medvac IVIg on PIDPrimary immunodeficiency disorder.D84.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.D84.9IRCT20101012004920N9Medvac BioPharma Company50
Completed
Not Applicable
Effect of anterior chamber paracentesis to control the pressure of the eye after cataract surgeryIRCT20091030002647N2Kerman University of Medical Sciences68
Completed
Not Applicable
Examination of the adverse event related to influenza virus vaccines in children with idiopathic nephrotic syndromeidiopathic nephrotic syndromeJPRN-UMIN000028658Kakogawa central city hospital40